Guy Montay
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 33
- Antibiotics Pharmacokinetics and Efficacy 30
- Oncology 23
- Cancer Treatment and Pharmacology 11
- Drug Transport and Resistance Mechanisms 11
- Co-authors
- René Bruno (12 shared papers)J. Vergniol (3 shared papers)Nicole Vivier (6 shared papers)Françoise Roquet (4 shared papers)A. Le Liboux (10 shared papers)Armand Frydman (11 shared papers)Lewis B. Sheiner (1 shared paper)Vijay O. Bhargava (6 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (7 papers)Clinical Pharmacology & Therapeutics (6 papers)The Journal of Clinical Pharmacology (6 papers)Investigational New Drugs (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- FranceUnited StatesAustria
In The Last Decade
Guy Montay
58 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Molecular Medicine 235
- Pharmacology 679
- Internal Medicine 116
- Pharmacology 236
- Oncology 658
Countries citing papers authored by Guy Montay
This map shows the geographic impact of Guy Montay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Montay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Montay more than expected).
Fields of papers citing papers by Guy Montay
This network shows the impact of papers produced by Guy Montay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Montay. The network helps show where Guy Montay may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy Montay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 224 | |
| 2 | 1984 | 146 | |
| 3 | 2002 | 144 | |
| 4 | 1996 | 99 | |
| 5 | 1992 | 99 | |
| 6 | 1992 | 93 | |
| 7 | 2001 | 88 | |
| 8 | 1997 | 68 | |
| 9 | 1985 | 60 | |
| 10 | 1997 | 55 | |
| 11 | 1996 | 54 | |
| 12 | 1997 | 52 | |
| 13 | 1992 | 50 | |
| 14 | 2005 | 48 | |
| 15 | 1998 | 46 | |
| 16 | 2002 | 43 | |
| 17 | 1999 | 43 | |
| 18 | Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance. | 1997 | 42 |
| 19 | 1983 | 35 | |
| 20 | 1994 | 34 |
About Guy Montay
Guy Montay is a scholar working on Pharmacology, Oncology, Molecular Biology, Epidemiology and Infectious Diseases, having authored 60 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (30 papers), Cancer Treatment and Pharmacology (11 papers), Drug Transport and Resistance Mechanisms (11 papers), Pneumonia and Respiratory Infections (7 papers), Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers), Antifungal resistance and susceptibility (4 papers) and Epilepsy research and treatment (4 papers). The work is most often cited by research in Molecular Medicine (235 citations), Pharmacology (679 citations), Internal Medicine (116 citations), Pharmacology (236 citations) and Oncology (658 citations). Guy Montay has collaborated with scholars based in France, United States and Austria. Frequent co-authors include René Bruno, J. Vergniol, Nicole Vivier, Françoise Roquet, A. Le Liboux, Armand Frydman, Lewis B. Sheiner, Vijay O. Bhargava, Michel G. Bergeron and Gerald Rhodes. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, Investigational New Drugs and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.